SCHEMBL8529263

SCHEMBL8529263

NC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO

nearest known ligand 0.69

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
TDP1 Q9NUW8 2/20 0.65
USP2 O75604 1/20 0.48
SLCO1B1 Q9Y6L6 1/20 0.48
KDM4E B2RXH2 2/20 0.46
PDE4A P27815 1/20 0.46
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
TOP1 P11387 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
MGAM O43451 2/20 0.31
SI P14410 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4074456 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL17813049 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL19426268 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL14282838 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL23485849 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL8531995 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL24398891 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL2361 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL2362 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1
SCHEMBL8625934 1.00 LMNA (0.69) LMNAL3MBTL1TDP1USP2SLCO1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181194-B2 Production of caprolactam from carbohydrate-containing materials RENNOVIA INC. (US) 2015-11-10 US claimed
EP-2697202-A1 PRODUCTION OF CAPROLACTAM FROM CARBOHYDRATE-CONTAINING MATERIALS Rennovia, Inc. (US) 2014-02-19 EP claimed
US-20120264908-A1 PRODUCTION OF CAPROLACTAM FROM CARBOHYDRATE-CONTAINING MATERIALS RENNOVIA, INC. (US) 2012-10-18 US claimed
WO-2012141915-A1 PRODUCTION OF CAPROLACTAM FROM CARBOHYDRATE-CONTAINING MATERIALS RENNOVIA, INC. (US) 2012-10-18 WO claimed
US-9181194-B2 Production of caprolactam from carbohydrate-containing materials RENNOVIA INC. (US) 2015-11-10 US disclosed
EP-2697202-A1 PRODUCTION OF CAPROLACTAM FROM CARBOHYDRATE-CONTAINING MATERIALS Rennovia, Inc. (US) 2014-02-19 EP disclosed
US-20120264908-A1 PRODUCTION OF CAPROLACTAM FROM CARBOHYDRATE-CONTAINING MATERIALS RENNOVIA, INC. (US) 2012-10-18 US disclosed
WO-2012141915-A1 PRODUCTION OF CAPROLACTAM FROM CARBOHYDRATE-CONTAINING MATERIALS RENNOVIA, INC. (US) 2012-10-18 WO disclosed
US-5844103-A Anionic glycasuccinamide sufactants and a process for their manufacture LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1998-12-01 US disclosed
US-5786468-A NONIONIC SURFACTANTS DERIVED FROM CARBOHYDRATES FOR SHAMPOO, DEODORANTS OR CLEANING COMPOUNDS LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1998-07-28 US disclosed
US-5750733-A Hydroxy containing alkyl glycamides, low foaming detergent compositions comprising such and a process for their manufacture LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1998-05-12 US disclosed
US-5631389-A SUCCINAMIDES WITH SUGAR GROUPS, POLLUTION CONTROL, BIODEGRADABLE LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1997-05-20 US disclosed
US-5541341-A CARBOHYDRATE BASED SURFACTANTS LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1996-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264908-A1 PRODUCTION OF CAPROLACTAM FROM CARBOHYDRATE-CONTAINING MATERIALS HAAO, HPD, ACMSD LMNA 3113/4885L3MBTL1 4342/4885TDP1 4260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.